Weiss, Markus
Wendel-Garcia, Pedro David
Cannizzaro, Vincenzo
Grass, Beate
Buehler, Philipp Karl
Kleine-Brueggeney, Maren
Funding for this research was provided by:
University of Zurich
Article History
Received: 13 September 2023
Accepted: 26 October 2023
First Online: 8 December 2023
Declarations
:
: MW serves as a consultant for medical device industries and has received consultant honoraria from BD. MW is cofounder of Silberspross GmbH Zurich, Switzerland, an innovation company advancing safety of intravenous drug therapy holding a patent on a new infusion access port. All other authors have no relevant financial or non-financial interests to disclose.
: The study did not include humans or animals so there was no need for ethical approval.
: Accordingly there was no need for a consent to participate in this laboratory study and accordingly we did not make an informed consent statement in this manuscript.
: The study did not include humans or animals so there was no need for ethical approval. No data or picutres of humans or animals are included in the manuscript. Only technical equiment was tested in the lab.